A multicenter, double-blind, placebo-controlled randomized study of bicifadine 200 mg BID in the treatment of chronic low back pain,

Trial Profile

A multicenter, double-blind, placebo-controlled randomized study of bicifadine 200 mg BID in the treatment of chronic low back pain,

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2007

At a glance

  • Drugs Bicifadine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 02 Feb 2007 Status changed from in progress to completed.
    • 25 Sep 2006 Status change
    • 22 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top